Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
How is diversity and inclusivity relevant for start-ups? And what can you do as a start-up to contribute to these themes? IXA sits down with Michael Musandu and Bouchra Talidi to talk about the benefits of building a diverse and inclusive start-up and to receive some tips on how to do so.
What is it like to participate in the Amsterdam Science & Innovation Award? We spoke to Dr Monalisa Goswami about her participation in 2017. The Amsterdam Science and Innovation Award is “a celebration of innovation coming out from scientists,” says Monalisa. “It makes you feel special.” The Amsterdam Science and Innovation Award (AmSIA) is the […]
How do you create a team and find financial support when you launch a start-up? IXA talked to postdoctoral researcher and entrepreneur Alexander Kostenko. When Alexander launched his start-up Photosynthetic in 2019 to build a new kind of 3D printer, he didn’t have a team yet, nor financial resources. Now, he has found a team […]